Mylan hit with class-action lawsuit over EpiPen Pricing

April 3, 2017

Monday Mylan was hit with a class-action lawsuit accusing them of illegally inflating EpiPen prices. In an interview with Wes Venteicher of the Trib, Dr. Gellad speaks to the fact that although Mylan is specifically names in the suit, it's a general indictment of drug pricing in general.